These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 2369707)
41. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. Heath EI; Burtness BA; Heitmiller RF; Salem R; Kleinberg L; Knisely JP; Yang SC; Talamini MA; Kaufman HS; Canto MI; Topazian M; Wu TT; Olukayode K; Forastiere AA J Clin Oncol; 2000 Feb; 18(4):868-76. PubMed ID: 10673530 [TBL] [Abstract][Full Text] [Related]
42. [A case of advanced esophageal cancer successfully treated by concurrent use of radiotherapy and low-dose CDDP and continuous infusion of 5-FU]. Miyaji N; Miki T; Ito Y; Takeshita T; Churei H; Hiraki Y; Nakajo M; Fukumoto T; Aiko T; Maenohara S; Minamimagari H Gan To Kagaku Ryoho; 1997 Mar; 24(5):601-4. PubMed ID: 9087295 [TBL] [Abstract][Full Text] [Related]
43. Phase II clinical trial with 5-fluorouracil, recombinant interferon-alpha-2b, and cisplatin for patients with metastatic or regionally advanced carcinoma of the esophagus. Wadler S; Haynes H; Beitler JJ; Hu X; Fell S; Camacho M; Levine B; Wiernik PH Cancer; 1996 Jul; 78(1):30-4. PubMed ID: 8646722 [TBL] [Abstract][Full Text] [Related]
44. Combined modality treatment with full-dose chemotherapy and concomitant boost radiotherapy for advanced head and neck carcinoma. Kutter J; Ozsahin M; Monnier P; Stupp R Eur Arch Otorhinolaryngol; 2005 Jan; 262(1):1-7. PubMed ID: 15004704 [TBL] [Abstract][Full Text] [Related]
45. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer. Kohno N; Kitahara S; Tamura E; Tanabe T Oncology; 2002; 63(3):226-31. PubMed ID: 12381901 [TBL] [Abstract][Full Text] [Related]
46. Ten-year survival with chemotherapy and radiotherapy in patients with squamous cell carcinoma of the esophagus. Bidoli P; Bajetta E; Stani SC; De CD; Santoro A; Valente M; Zucali R; Valagussa P; Ravasi G; Bonadonna G Cancer; 2002 Jan; 94(2):352-61. PubMed ID: 11900221 [TBL] [Abstract][Full Text] [Related]
47. First-line chemotherapy improves the resection rate and long-term survival of locally advanced (T4, any N, M0) squamous cell carcinoma of the thoracic esophagus: final report on 163 consecutive patients with 5-year follow-up. Ancona E; Ruol A; Castoro C; Chiarion-Sileni V; Merigliano S; Santi S; Bonavina L; Peracchia A Ann Surg; 1997 Dec; 226(6):714-23; discussion 723-4. PubMed ID: 9409570 [TBL] [Abstract][Full Text] [Related]
48. Concurrent radiotherapy and chemotherapy with protracted continuous infusion of 5-fluorouracil in inoperable esophageal squamous cell carcinoma. Sakai K; Inakoshi H; Sueyama H; Oda J; Ito T; Tsuchida E; Sugita T; Matsumoto Y; Saito M; Saito A Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):921-7. PubMed ID: 7860407 [TBL] [Abstract][Full Text] [Related]
49. The clinical efficacy of consolidation chemotherapy for resectable esophageal squamous cell cancer after trimodality therapy. Sun Y; Cheng S; Lu Y; Zheng X; Ye K; Ge H J Cancer Res Ther; 2016; 12(1):90-5. PubMed ID: 27072217 [TBL] [Abstract][Full Text] [Related]
50. Concurrent chemoradiotherapy for esophageal cancer with malignant fistula. Koike R; Nishimura Y; Nakamatsu K; Kanamori S; Shibata T Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1418-22. PubMed ID: 18234437 [TBL] [Abstract][Full Text] [Related]
51. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer. Vokes EE; Haraf DJ; Brockstein BE; Weichselbaum RR Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):70-6. PubMed ID: 10210543 [TBL] [Abstract][Full Text] [Related]
52. Outcomes from chemoradiotherapy for patients with esophageal cancer. Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614 [TBL] [Abstract][Full Text] [Related]
53. Phase I/II study of divided-dose docetaxel, cisplatin and fluorouracil for patients with recurrent or metastatic squamous cell carcinoma of the esophagus. Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Matsumura S; Iwahashi M; Yamaue H Dis Esophagus; 2017 Feb; 30(2):1-7. PubMed ID: 26725778 [TBL] [Abstract][Full Text] [Related]
55. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study. Choi N; Park SD; Lynch T; Wright C; Ancukiewicz M; Wain J; Donahue D; Mathisen D Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):111-22. PubMed ID: 15337546 [TBL] [Abstract][Full Text] [Related]
56. [Split-course concomitant radiochemotherapy plus surgery vs. surgery alone in squamous cell carcinoma of the esophagus. A non-randomized retrospective study of 184 patients]. Malhaire JP; Lozac'h P; Simon H; Labat JP; Topart P; Lucas B; Metges JP; Lamezec B Bull Cancer; 1997 Apr; 84(4):357-67. PubMed ID: 9238158 [TBL] [Abstract][Full Text] [Related]
57. Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. Psyrri A; Kwong M; DiStasio S; Lekakis L; Kassar M; Sasaki C; Wilson LD; Haffty BG; Son YH; Ross DA; Weinberger PM; Chung GG; Zelterman D; Burtness BA; Cooper DL J Clin Oncol; 2004 Aug; 22(15):3061-9. PubMed ID: 15284256 [TBL] [Abstract][Full Text] [Related]
58. Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients. Doci R; Zucali R; La Monica G; Meroni E; Kenda R; Eboli M; Lozza L J Clin Oncol; 1996 Dec; 14(12):3121-5. PubMed ID: 8955657 [TBL] [Abstract][Full Text] [Related]
59. [Accelerated hyperfractionated simultaneous radiochemotherapy in advanced head-neck carcinomas in comparison: split course and concomitant boost concept]. Dietz A; Rudat V; Nollert J; Flentje M; Maiei H; Wannenmacher M; Weidauer H Laryngorhinootologie; 1996 Dec; 75(12):745-53. PubMed ID: 9081280 [TBL] [Abstract][Full Text] [Related]
60. Phase II study of chemoradiotherapy for advanced squamous cell carcinoma of the thoracic esophagus: nine Japanese institutions trial. Ishida K; Iizuka T; Ando N; Ide H Jpn J Clin Oncol; 1996 Oct; 26(5):310-5. PubMed ID: 8895670 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]